Beyond Air, Inc. Asset Impairment Charges
Beyond Air, Inc. (XAIR) reported Asset Impairment Charges of $334.00 thousand for the 9-month period ending 2024-12-31, per its 10-Q filed 2025-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2025-02-10
- Beyond Air, Inc. asset impairment charges for the quarter ending 2024-12-31 was $163.00K.
- Beyond Air, Inc. asset impairment charges for the quarter ending 2023-03-31 was $0.00.
- Beyond Air, Inc. asset impairment charges for the quarter ending 2022-12-31 was $0.00.
- Beyond Air, Inc. asset impairment charges for fiscal 2024 was $15.00K, a 93.62% decline from fiscal 2023.
- Beyond Air, Inc. asset impairment charges for fiscal 2023 was $235.00K.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2024-12-31 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-10 | $334.00K 10-Q · filed 2025-02-10 | ||
| 2024-09-30 | $171.00K 10-Q · filed 2024-11-12 | |||
| 2024-03-31 | $15.00K 10-K · filed 2024-06-24 | |||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $0.00 derived: sum of 2 quarters · filed 2024-06-24 | $235.00K 10-K · filed 2024-06-24 | |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12 | $235.00K 10-Q · filed 2024-02-12 | ||
| 2022-09-30 | $235.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |